FY2025 · ended Dec 31, 2025 · Revenue $42.48M, +105.7% YoY · Filed Mar 10, 2026
SS Innovations International, Inc. (SSII) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $42.5 million and a net loss of $12.1 million. Free cash flow was -$22.2 million. As of Jun 30, 2026 it held $13.6 million in cash and investments and $3.2 million in total debt.
Revenue (TTM)
$52.40M
+89.7% vs year-ago TTM
Net income (TTM)
$-12.43M
-11.9% vs year-ago TTM
Operating cash flow (TTM)
$-15.53M
-1.1% vs year-ago TTM
Free cash flow
$-22.20M
-118.4% vs prior year
EPS (TTM)
$-0.06
-2.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
200.23M
+3.4% vs prior year
Net cash
$10.41M
as of Jun 30, 2026
Operating margin
-16.2%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SSII (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Gurugram
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1676163
- Former names
- SS Innovations International, Inc. (until Oct 26, 2026); AVRA Medical Robotics, Inc. (until Apr 14, 2023)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $42.5M | $20.6M | $5.9M | — | — |
| Operating income | -$8.2M | -$19.0M | -$20.3M | — | — |
| Net income | -$12.1M | -$19.2M | -$20.9M | -$3.2M | -$1.5M |
| Diluted EPS | -$0.06 | -$0.11 | -$0.14 | -$0.03 | -$0.05 |
| Operating cash flow | -$18.5M | -$9.5M | -$15.4M | -$6.0M | -$363,034 |
| Free cash flow | -$22.2M | -$10.2M | -$15.8M | — | — |
| Total assets | $74.2M | $42.4M | $31.5M | $7.0M | $428,607 |
| Total liabilities | $36.0M | $28.9M | $11.8M | — | — |
| Stockholders' equity | $38.2M | $13.5M | $19.7M | -$2.7M | $585,611 |
| Cash and investments | $3.2M | $466,500 | $2.0M | — | $405,774 |
| Total debt | $2.9M | $2.8M | $3.3M | $469,017 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 13, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 26, 2026 | Aug 21, 2026 |
All 309 SS Innovations International, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.